$17.35 -0.37 (-2.09%)
2/10/2012 4:01 PM

Emergent BioSolutions, Inc. (NYSE:EBS)

CAPS Rating: 5 out of 5

A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.

Recs

1
Player Avatar sprucemoose2 (52.49) Submitted: 1/5/2009 2:27:31 PM : Outperform Start Price: $26.07 EBS Score: -80.77

has a constant revenue stream from the good ole US of A and sticks to its 50 day MA very well

Report this Post Add Comment

Featured Broker Partners


Advertisement